Danfeng Ren Selected Research

Danfeng Ren Research Topics

3	Hepatitis B 10/2019 - 01/2019
2	Inflammation (Inflammations) 12/2023 - 01/2023
2	Infections 10/2019 - 01/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2023
1	Venous Thromboembolism 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Hemorrhage 01/2023
1	Hepatitis 01/2021
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Pathologic Constriction (Stenosis) 10/2016

2	Tenofovir (Viread)FDA Link 10/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2019
1	Mitogen-Activated Protein Kinase 14IBA 12/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	AnticoagulantsIBA 01/2023
1	InterferonsIBA 01/2021
1	liposomal amphotericin B FDA Link 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2019
1	Telbivudine FDA Link 10/2019
1	hepatitis B hyperimmune globulinIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019

3	Therapeutics 01/2023 - 01/2019
1	Ischemic Postconditioning 10/2016